# Parkinson’s Disease Patients Face Higher 90-Day Readmission, Reoperation, and Infection Risk Following Total Knee Arthroplasty

**Authors:** David Maman, Yaniv Steinfeld, Yaron Berkovich

PMC · DOI: 10.1016/j.artd.2026.101970 · 2026-02-28

## TL;DR

Parkinson’s disease patients are more likely to be readmitted after knee replacement surgery, often due to infections and needing more procedures.

## Contribution

This study identifies higher readmission and complication risks for Parkinson’s patients after TKA using a large national database.

## Key findings

- PD patients had a 13.0% readmission rate compared to 7.3% in non-PD patients.
- Infection-related readmissions were more common in PD patients (4.1% vs 2.2%).
- Readmission costs were higher for PD patients ($63,023 vs $48,855).

## Abstract

Parkinson’s disease (PD) is an increasingly common comorbidity in patients undergoing total knee arthroplasty (TKA), yet its impact on readmissions remains poorly defined.

Using the Nationwide Readmissions Database 2020-2022, we identified elective, primary TKA cases. Patients with oncologic diagnoses, COVID-19-related admissions, acute fractures, and contralateral knee arthroplasty were excluded. Only the first readmission within 90 days was analyzed. Propensity score matching (1:1) was performed for demographics, comorbidities, hospital factors, and primary payer. The primary outcome was 90-day readmission. Secondary outcomes included infection-related readmissions, surgical procedures during readmission, readmission length of stay, readmission costs, and in-hospital mortality.

After matching, 7286 patients were included (3675 PD vs 3611 non-PD). PD patients had a significantly higher 90-day readmission rate (13.0% vs 7.3%; P < .01). Infection-related readmissions (4.1% vs 2.2%; P < .01) and surgical procedures during readmission (7.5% vs 4.1%; P < .01) were more frequent in PD patients. Readmission length of stay was longer (5.9 vs 4.1 days; P < .01), and readmission costs were higher ($63,023 vs $48,855; P < .01). In-hospital mortality during readmission was also higher in PD patients (0.3% vs 0.1%; P < .01).

PD is associated with a significantly higher risk of 90-day readmission following TKA, with readmissions frequently involving infection-related complications and surgical intervention. These findings highlight the importance of tailored perioperative care and enhanced postdischarge monitoring in this vulnerable population.

Level III.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180), infection (MONDO:0005550)

## Full-text entities

- **Diseases:** chronic kidney disease (MESH:D051436), diabetes (MESH:D003920), alcohol abuse (MESH:D000437), wound dehiscence (MESH:D013529), PD (MESH:D010300), dyslipidemia (MESH:D050171), fracture (MESH:D050723), Sarcopenia (MESH:D055948), neurodegenerative disorder (MESH:D019636), Autonomic dysfunction (MESH:D001342), frailty (MESH:D000073496), periprosthetic joint infection (MESH:D057068), gastrointestinal dysmotility (MESH:D015154), pneumonia (MESH:D011014), delirium (MESH:D003693), chronic lung disease (MESH:D029424), obesity (MESH:D009765), respiratory insufficiency (MESH:D012131), osteoporosis (MESH:D010024), urinary tract infection (MESH:D014552), wound infection (MESH:D014946), orthostatic hypotension (MESH:D007024), COVID-19 (MESH:D000086382), bacteremia (MESH:D016470), Infection (MESH:D007239), urinary retention (MESH:D016055), bradykinesia (MESH:D018476), tremor (MESH:D014202), Mortality (MESH:D003643), hypertension (MESH:D006973), postural instability (MESH:D054972), dysphagia (MESH:D003680), TKA (MESH:D007718), anemia (MESH:D000740), sepsis (MESH:D018805), cognitive impairment (MESH:D003072), oncologic (MESH:D000072716), rigidity (MESH:D009127), postoperative infection (MESH:D013530), aspiration (MESH:D011015), congestive heart failure (MESH:D006333), cellulitis (MESH:D002481), thyroid disease (MESH:D013959), obstructive sleep apnea (MESH:D020181)
- **Chemicals:** dopamine (MESH:D004298)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966648/full.md

---
Source: https://tomesphere.com/paper/PMC12966648